Kuehn Law investigates TG Therapeutics officers and directors for potential fiduciary breaches

GlobeNewswire··Read original
2▲0 ▼1Impact / 5
Summary · why it matters

Kuehn Law, PLLC is investigating whether certain officers and directors of TG Therapeutics, Inc. breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms. Long-term TGTX stockholders are encouraged to contact Justin Kuehn, Esq. at justin@kuehn.law or (833) 672-0814 for a free consultation with no obligation.

Impact on assets 1

Biotech & Genomic Medicine▼ · 1 stocks
TG Therapeutics Inc
TGTX
▼ NegativeRegulationrelevance

Investigation for fiduciary breaches and potential self-dealing by officers/directors

© 2026 MarketIVNews